During the last session, Co-Diagnostics Inc (NASDAQ:CODX)’s traded shares were 0.47 million, with the beta value of the company hitting 0.53. The 52-week high for the CODX share is $2.23, that puts it down -792.0 from that peak though still a striking 8.0% gain since the share price plummeted to a 52-week low of $0.23. The company’s market capitalization is $8.43M, and the average intraday trading volume over the past 10 days was 1.57 million shares, and the average trade volume was 597.44K shares over the past three months.
Co-Diagnostics Inc (NASDAQ:CODX) trade information
Co-Diagnostics Inc (CODX) registered a -0.75% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.75% in intraday trading to $0.25, hitting a weekly high. The stock’s 5-day price performance is -9.75%, and it has moved by -14.27% in 30 days. Based on these gigs, the overall price performance for the year is -66.67%. The short interest in Co-Diagnostics Inc (NASDAQ:CODX) is 0.28 million shares and it means that shorts have 0.41 day(s) to cover.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 95.83% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, CODX is trading at a discount of -2300.0% off the target high and -2300.0% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -27.40%. While earnings are projected to return 13.71% in 2025, the next five years will return 37.69% per annum.
CODX Dividends
Co-Diagnostics Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Co-Diagnostics Inc (NASDAQ:CODX)’s Major holders
Co-Diagnostics Inc insiders own 9.00% of total outstanding shares while institutional holders control 17.44%, with the float percentage being 19.17%. VANGUARD GROUP INC is the largest shareholder of the company, while 45.0 institutions own stock in it. As of 2024-06-30, the company held over 1.78 million shares (or 5.913% of all shares), a total value of $2.23 million in shares.
The next largest institutional holding, with 0.59 million shares, is of RENAISSANCE TECHNOLOGIES LLC’s that is approximately 1.9486% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.73 million.
Also, the Mutual Funds coming in first place with the largest holdings of Co-Diagnostics Inc (CODX) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 1.28 shares. This amounts to just over 3.80 percent of the company’s overall shares, with a $0.32 million market value. The same data shows that the other fund manager holds slightly less at 444.78, or about 1.32% of the stock, which is worth about $0.11 million.
